Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Centre Oscar Lambret
Mayo Clinic
University of California, Irvine
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Ossium Health, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Essen Biotech
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Hadassah Medical Organization
Hadassah Medical Organization
Valo Therapeutics Oy
Herlev Hospital
University of Pittsburgh
City of Hope Medical Center
Thomas Jefferson University
City of Hope Medical Center
The Netherlands Cancer Institute
University of Pittsburgh
ImmunityBio, Inc.
ImmunityBio, Inc.
Centre Hospitalier Universitaire Vaudois
Vall d'Hebron Institute of Oncology
M.D. Anderson Cancer Center
University of Pennsylvania
M.D. Anderson Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University of Kansas Medical Center
BioEclipse Therapeutics